UC Irvine team: Alzheimer's vax shows promise

Research presented this week at the Society for Neuroscience meeting showed one vaccine candidate appears both safe and effective in an animal model. A UC Irvine team tested a vaccine developed against a non-human protein that is similar to amyloid-beta but has a different sequence of amino acids. Because the protein in the vaccine is non-human, it's hoped that the vaccine would not cause inflammation. "The idea is if we can overcome this auto-inflammatory reaction, we might be able to develop a safe vaccine," said the senior author of the study, neuroscientist Charles Glabe of UC Irvine, at a news conference Tuesday in San Diego. Report

Suggested Articles

Former FDA Commissioner Scott Gottlieb says 40% of the population needs to be vaccinated to achieve COVID-19 herd immunity.

CanSino Bio, Moderna and a collaboration between Oxford Univeristy and AstraZeneca are frontrunners, but they all face hurdles shared and unique.

Merck & Co. inked a series of deals to advance three COVID-19 projects, trailing some of its large pharma peers into the industrywide research effort.